Roden DM - Search Results

1

Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.

Weeke P, Mosley JD, Hanna D, Delaney JT, Shaffer C, Wells QS, Van Driest S, Karnes JH, Ingram C, Guo Y, Shyr Y, Norris K, Kannankeril PJ, Ramirez AH, Smith JD, Mardis ER, Nickerson D, George AL Jr, Roden DM. Weeke P, et al. Among authors: roden dm. J Am Coll Cardiol. 2014 Apr 15;63(14):1430-7. doi: 10.1016/j.jacc.2014.01.031. Epub 2014 Feb 19. J Am Coll Cardiol. 2014. PMID: 24561134 Free PMC article.

2

The long QT syndromes: genetic basis and clinical implications.

Chiang CE, Roden DM. Chiang CE, et al. Among authors: roden dm. J Am Coll Cardiol. 2000 Jul;36(1):1-12. doi: 10.1016/s0735-1097(00)00716-6. J Am Coll Cardiol. 2000. PMID: 10898405 Free article. Review.

3

Cardiac ion channels.

Roden DM, Balser JR, George AL Jr, Anderson ME. Roden DM, et al. Annu Rev Physiol. 2002;64:431-75. doi: 10.1146/annurev.physiol.64.083101.145105. Annu Rev Physiol. 2002. PMID: 11826275 Review.

4

Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome.

Kanki H, Yang P, Xie HG, Kim RB, George AL Jr, Roden DM. Kanki H, et al. Among authors: roden dm. J Cardiovasc Electrophysiol. 2002 Mar;13(3):252-6. doi: 10.1046/j.1540-8167.2002.00252.x. J Cardiovasc Electrophysiol. 2002. PMID: 11942593

5

Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.

Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL Jr, Roden DM. Yang P, et al. Among authors: roden dm. Circulation. 2002 Apr 23;105(16):1943-8. doi: 10.1161/01.cir.0000014448.19052.4c. Circulation. 2002. PMID: 11997281

6

The genetic basis of variability in drug responses.

Roden DM, George AL Jr. Roden DM, et al. Nat Rev Drug Discov. 2002 Jan;1(1):37-44. doi: 10.1038/nrd705. Nat Rev Drug Discov. 2002. PMID: 12119608 Review.

7

The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines.

Kupershmidt S, Yang IC, Hayashi K, Wei J, Chanthaphaychith S, Petersen CI, Johns DC, George AL Jr, Roden DM, Balser JR. Kupershmidt S, et al. Among authors: roden dm. FASEB J. 2003 Dec;17(15):2263-5. doi: 10.1096/fj.02-1057fje. Epub 2003 Oct 2. FASEB J. 2003. PMID: 14525949

8

Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents.

Drolet B, Simard C, Roden DM. Drolet B, et al. Among authors: roden dm. Circulation. 2004 Jan 6;109(1):26-9. doi: 10.1161/01.CIR.0000109484.00668.CE. Epub 2003 Dec 22. Circulation. 2004. PMID: 14691044

9

Drug-induced prolongation of the QT interval.

Roden DM. Roden DM. N Engl J Med. 2004 Mar 4;350(10):1013-22. doi: 10.1056/NEJMra032426. N Engl J Med. 2004. PMID: 14999113 Review. No abstract available.

10

Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndrome.

Kannankeril PJ, Roden DM, Fish FA. Kannankeril PJ, et al. Among authors: roden dm. J Cardiovasc Electrophysiol. 2004 Jan;15(1):119. doi: 10.1046/j.1540-8167.2004.03369.x. J Cardiovasc Electrophysiol. 2004. PMID: 15028088 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

802 results

Search Page